Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease

Paricalcitol, a selective vitamin D receptor (VDR) activator used for treatment of secondary hyperparathyroidism in chronic kidney disease (CKD), has been associated with survival advantages, suggesting that this drug, beyond its ability to suppress parathyroid hormone, may have additional beneficia...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Donate-Correa, J., Domínguez-Pimentel, V., Méndez-Pérez, M. L., Muros-de-Fuentes, M., Mora-Fernández, C., Martín-Núñez, E., Cazaña-Pérez, V., Navarro-González, J. F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2014
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913352/
https://ncbi.nlm.nih.gov/pubmed/24511210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/670475
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi